Clinical trials whose results are overdue — by the statutory deadline.

US law requires applicable clinical trials to post results to ClinicalTrials.gov within 1 year of primary completion. Many don't. We compute the bright-line deadline and flag every trial that's past it with results still unposted — a citable public-record fact, not an accusation.

See the overdue feed →API

5,860industry FDA-regulated drug trials past deadline, results unposted (CT.gov scope)

500flagged & provenance-stamped in current snapshot

Most overdue right now

3076d

Jiangsu Yahong Meditech Co., Ltd aka AsierisNCT04498702Study of Continuous APL-1202 Treatment in Subjects With High-Risk Non-Mu

3074d

Novartis PharmaceuticalsNVSNCT02205398Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Pos

3064d

Novartis PharmaceuticalsNVSNCT02520752A DDI Study to Assess the Effect of INC280 on the PK of Midazolam and Ca

3063d

Eisai Inc.NCT02583451Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Pe

3063d

BayerNCT01973868Safety and Pharmacokinetics of Regorafenib and Cetuximab in Combination

3062d

BayerNCT02122913A Study to Test the Safety of the Investigational Drug Larotrectinib in

3062d

BPGbioNCT01957735BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to

3059d

Janssen Research & Development, LLCNCT02933580A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ

Full sortable feed →

Why this is the one signal that holds up

Deterministic

A statutory deadline (primary completion + 365 days), not an interpretive judgment. The math is the same for everyone.

Citable & defamation-safe

We state public-record facts with the official source link. Never "fraud" or "violation" — those are legal conclusions we don't make.

Provenance-stamped

Every flag is hash-chained: we can prove we flagged trial X as overdue on date Y. Tamper-evident, free, in-KV.

Who buys this

Securities-litigation firms — for public sponsors, overdue results are a disclosure/scienter angle worth surfacing early.
Biotech short research — reporting hygiene as a governance/operational tell, mapped to ticker.
Compliance / CRO QA — monitor your own and competitors' reporting posture against the bright-line clock.
Pharmacovigilance — unreported results = missing safety signal in the public record.

Pricing & access →

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →